Review



goat anti ang2 primary antibody  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 93
      Buy from Supplier

    Structured Review

    R&D Systems goat anti ang2 primary antibody
    Comparison of <t>Ang2,</t> podoplanin, and CLEC-2 staining in female and male patients treated with TKIs (50 µm scale bar). ( A ) 63× image of Ang2 staining in tumor and endothelial tissue (red arrows for endothelia) of a female patient. ( B ) 63× image of Ang2 staining in tumor and endothelial tissue (red arrows for endothelia) of a male patient. ( C ) 63× image of podoplanin staining at the level of the lymphatic endothelium in a female patient. ( D ) 63× image of podoplanin staining at the level of the lymphatic endothelium in a male patient. ( E ) 63× image of CLEC-2 staining at the level of tumor tissue in a female patient. ( F ) 63× image of CLEC-2 staining at the level of tumor tissue in a male patient.
    Goat Anti Ang2 Primary Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 48 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/goat+anti+ang2+primary+antibody/Human+Angiopoietin-2+Antibody/pmc11273995-103-5-10
    Average 93 stars, based on 48 article reviews
    goat anti ang2 primary antibody - by Bioz Stars, 2026-08
    93/100 stars

    Images

    1) Product Images from "Differential Impact of Tumor Endothelial Angiopoietin-2 and Podoplanin in Lymphatic Endothelial Cells on HCC Outcomes with Tyrosine Kinase Inhibitor Treatment According to Sex"

    Article Title: Differential Impact of Tumor Endothelial Angiopoietin-2 and Podoplanin in Lymphatic Endothelial Cells on HCC Outcomes with Tyrosine Kinase Inhibitor Treatment According to Sex

    Journal: Biomedicines

    doi: 10.3390/biomedicines12071424

    Comparison of Ang2, podoplanin, and CLEC-2 staining in female and male patients treated with TKIs (50 µm scale bar). ( A ) 63× image of Ang2 staining in tumor and endothelial tissue (red arrows for endothelia) of a female patient. ( B ) 63× image of Ang2 staining in tumor and endothelial tissue (red arrows for endothelia) of a male patient. ( C ) 63× image of podoplanin staining at the level of the lymphatic endothelium in a female patient. ( D ) 63× image of podoplanin staining at the level of the lymphatic endothelium in a male patient. ( E ) 63× image of CLEC-2 staining at the level of tumor tissue in a female patient. ( F ) 63× image of CLEC-2 staining at the level of tumor tissue in a male patient.
    Figure Legend Snippet: Comparison of Ang2, podoplanin, and CLEC-2 staining in female and male patients treated with TKIs (50 µm scale bar). ( A ) 63× image of Ang2 staining in tumor and endothelial tissue (red arrows for endothelia) of a female patient. ( B ) 63× image of Ang2 staining in tumor and endothelial tissue (red arrows for endothelia) of a male patient. ( C ) 63× image of podoplanin staining at the level of the lymphatic endothelium in a female patient. ( D ) 63× image of podoplanin staining at the level of the lymphatic endothelium in a male patient. ( E ) 63× image of CLEC-2 staining at the level of tumor tissue in a female patient. ( F ) 63× image of CLEC-2 staining at the level of tumor tissue in a male patient.

    Techniques Used: Comparison, Staining

    Ang2, podoplanin, and CLEC-2 staining intensity (expressed as optical density (OD)) in HCC patients treated with TKIs stratified according to sex.
    Figure Legend Snippet: Ang2, podoplanin, and CLEC-2 staining intensity (expressed as optical density (OD)) in HCC patients treated with TKIs stratified according to sex.

    Techniques Used: Staining

    Receiver operating characteristic (ROC) curve analysis to evaluate the diagnostic power of the LEC podoplanin ( A ) and of endothelial Ang2 ( B ) to predict extra-hepatic spread. The area under the ROC curves (AUCs) was analyzed using the Hanley and McNeil method . The AUC values were 0.839 (95% CI 0.679 to 0.999; p < 0.0001) and 0.821 (95% CI 0.652 to 0.989; p < 0.0001).
    Figure Legend Snippet: Receiver operating characteristic (ROC) curve analysis to evaluate the diagnostic power of the LEC podoplanin ( A ) and of endothelial Ang2 ( B ) to predict extra-hepatic spread. The area under the ROC curves (AUCs) was analyzed using the Hanley and McNeil method . The AUC values were 0.839 (95% CI 0.679 to 0.999; p < 0.0001) and 0.821 (95% CI 0.652 to 0.989; p < 0.0001).

    Techniques Used: Diagnostic Assay

    Univariate and multivariate Cox regression analysis for survival.
    Figure Legend Snippet: Univariate and multivariate Cox regression analysis for survival.

    Techniques Used: Biomarker Discovery



    Similar Products

    goat anti ang2 primary antibody  (R&D Systems)
    93
    R&D Systems goat anti ang2 primary antibody
    Comparison of <t>Ang2,</t> podoplanin, and CLEC-2 staining in female and male patients treated with TKIs (50 µm scale bar). ( A ) 63× image of Ang2 staining in tumor and endothelial tissue (red arrows for endothelia) of a female patient. ( B ) 63× image of Ang2 staining in tumor and endothelial tissue (red arrows for endothelia) of a male patient. ( C ) 63× image of podoplanin staining at the level of the lymphatic endothelium in a female patient. ( D ) 63× image of podoplanin staining at the level of the lymphatic endothelium in a male patient. ( E ) 63× image of CLEC-2 staining at the level of tumor tissue in a female patient. ( F ) 63× image of CLEC-2 staining at the level of tumor tissue in a male patient.
    Goat Anti Ang2 Primary Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/goat+anti+ang2+primary+antibody/Human+Angiopoietin-2+Antibody/pmc11273995-103-5-10
    Average 93 stars, based on 1 article reviews
    goat anti ang2 primary antibody - by Bioz Stars, 2026-08
    93/100 stars
    		  Buy from Supplier
    human angiopoietin-2 antibody  (Bio-Techne corporation)
    99
    Bio-Techne corporation human angiopoietin-2 antibody
    Comparison of <t>Ang2,</t> podoplanin, and CLEC-2 staining in female and male patients treated with TKIs (50 µm scale bar). ( A ) 63× image of Ang2 staining in tumor and endothelial tissue (red arrows for endothelia) of a female patient. ( B ) 63× image of Ang2 staining in tumor and endothelial tissue (red arrows for endothelia) of a male patient. ( C ) 63× image of podoplanin staining at the level of the lymphatic endothelium in a female patient. ( D ) 63× image of podoplanin staining at the level of the lymphatic endothelium in a male patient. ( E ) 63× image of CLEC-2 staining at the level of tumor tissue in a female patient. ( F ) 63× image of CLEC-2 staining at the level of tumor tissue in a male patient.
    Human Angiopoietin 2 Antibody, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/goat+anti+ang2+primary+antibody/Human+Angiopoietin-2+Antibody/custom%40af623%4031402260
    Average 99 stars, based on 1 article reviews
    human angiopoietin-2 antibody - by Bioz Stars, 2026-08
    99/100 stars
    		  Buy from Supplier
    goat anti ang2 primary antibodies  (Santa Cruz Biotechnology)
    93
    Santa Cruz Biotechnology goat anti ang2 primary antibodies
    Comparison of <t>Ang2,</t> podoplanin, and CLEC-2 staining in female and male patients treated with TKIs (50 µm scale bar). ( A ) 63× image of Ang2 staining in tumor and endothelial tissue (red arrows for endothelia) of a female patient. ( B ) 63× image of Ang2 staining in tumor and endothelial tissue (red arrows for endothelia) of a male patient. ( C ) 63× image of podoplanin staining at the level of the lymphatic endothelium in a female patient. ( D ) 63× image of podoplanin staining at the level of the lymphatic endothelium in a male patient. ( E ) 63× image of CLEC-2 staining at the level of tumor tissue in a female patient. ( F ) 63× image of CLEC-2 staining at the level of tumor tissue in a male patient.
    Goat Anti Ang2 Primary Antibodies, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/goat+anti+ang2+primary+antibody/Ang-2+Antibody/pm20492297-69-18-22
    Average 93 stars, based on 1 article reviews
    goat anti ang2 primary antibodies - by Bioz Stars, 2026-08
    93/100 stars
    		  Buy from Supplier

    Image Search Results


    Comparison of Ang2, podoplanin, and CLEC-2 staining in female and male patients treated with TKIs (50 µm scale bar). ( A ) 63× image of Ang2 staining in tumor and endothelial tissue (red arrows for endothelia) of a female patient. ( B ) 63× image of Ang2 staining in tumor and endothelial tissue (red arrows for endothelia) of a male patient. ( C ) 63× image of podoplanin staining at the level of the lymphatic endothelium in a female patient. ( D ) 63× image of podoplanin staining at the level of the lymphatic endothelium in a male patient. ( E ) 63× image of CLEC-2 staining at the level of tumor tissue in a female patient. ( F ) 63× image of CLEC-2 staining at the level of tumor tissue in a male patient.

    Journal: Biomedicines

    Article Title: Differential Impact of Tumor Endothelial Angiopoietin-2 and Podoplanin in Lymphatic Endothelial Cells on HCC Outcomes with Tyrosine Kinase Inhibitor Treatment According to Sex

    doi: 10.3390/biomedicines12071424

    Figure Lengend Snippet: Comparison of Ang2, podoplanin, and CLEC-2 staining in female and male patients treated with TKIs (50 µm scale bar). ( A ) 63× image of Ang2 staining in tumor and endothelial tissue (red arrows for endothelia) of a female patient. ( B ) 63× image of Ang2 staining in tumor and endothelial tissue (red arrows for endothelia) of a male patient. ( C ) 63× image of podoplanin staining at the level of the lymphatic endothelium in a female patient. ( D ) 63× image of podoplanin staining at the level of the lymphatic endothelium in a male patient. ( E ) 63× image of CLEC-2 staining at the level of tumor tissue in a female patient. ( F ) 63× image of CLEC-2 staining at the level of tumor tissue in a male patient.

    Article Snippet: Sections were then incubated with goat anti-Ang2 primary antibody (AF623, R&D Systems, Inc., Minneapolis, MN, USA) at working dilution of 1:50 or mouse anti-podoplanin primary antibody (05463645001, Roche Diagnostics, Monza, MB, Italy), or rabbit anti-CLEC-2 primary antibody (LSB12627, LifeSpan BioSciences, Inc., Shirley, MA, USA) at working dilution of 1:50.

    Techniques: Comparison, Staining

    Ang2, podoplanin, and CLEC-2 staining intensity (expressed as optical density (OD)) in HCC patients treated with TKIs stratified according to sex.

    Journal: Biomedicines

    Article Title: Differential Impact of Tumor Endothelial Angiopoietin-2 and Podoplanin in Lymphatic Endothelial Cells on HCC Outcomes with Tyrosine Kinase Inhibitor Treatment According to Sex

    doi: 10.3390/biomedicines12071424

    Figure Lengend Snippet: Ang2, podoplanin, and CLEC-2 staining intensity (expressed as optical density (OD)) in HCC patients treated with TKIs stratified according to sex.

    Article Snippet: Sections were then incubated with goat anti-Ang2 primary antibody (AF623, R&D Systems, Inc., Minneapolis, MN, USA) at working dilution of 1:50 or mouse anti-podoplanin primary antibody (05463645001, Roche Diagnostics, Monza, MB, Italy), or rabbit anti-CLEC-2 primary antibody (LSB12627, LifeSpan BioSciences, Inc., Shirley, MA, USA) at working dilution of 1:50.

    Techniques: Staining

    Receiver operating characteristic (ROC) curve analysis to evaluate the diagnostic power of the LEC podoplanin ( A ) and of endothelial Ang2 ( B ) to predict extra-hepatic spread. The area under the ROC curves (AUCs) was analyzed using the Hanley and McNeil method . The AUC values were 0.839 (95% CI 0.679 to 0.999; p < 0.0001) and 0.821 (95% CI 0.652 to 0.989; p < 0.0001).

    Journal: Biomedicines

    Article Title: Differential Impact of Tumor Endothelial Angiopoietin-2 and Podoplanin in Lymphatic Endothelial Cells on HCC Outcomes with Tyrosine Kinase Inhibitor Treatment According to Sex

    doi: 10.3390/biomedicines12071424

    Figure Lengend Snippet: Receiver operating characteristic (ROC) curve analysis to evaluate the diagnostic power of the LEC podoplanin ( A ) and of endothelial Ang2 ( B ) to predict extra-hepatic spread. The area under the ROC curves (AUCs) was analyzed using the Hanley and McNeil method . The AUC values were 0.839 (95% CI 0.679 to 0.999; p < 0.0001) and 0.821 (95% CI 0.652 to 0.989; p < 0.0001).

    Article Snippet: Sections were then incubated with goat anti-Ang2 primary antibody (AF623, R&D Systems, Inc., Minneapolis, MN, USA) at working dilution of 1:50 or mouse anti-podoplanin primary antibody (05463645001, Roche Diagnostics, Monza, MB, Italy), or rabbit anti-CLEC-2 primary antibody (LSB12627, LifeSpan BioSciences, Inc., Shirley, MA, USA) at working dilution of 1:50.

    Techniques: Diagnostic Assay

    Univariate and multivariate Cox regression analysis for survival.

    Journal: Biomedicines

    Article Title: Differential Impact of Tumor Endothelial Angiopoietin-2 and Podoplanin in Lymphatic Endothelial Cells on HCC Outcomes with Tyrosine Kinase Inhibitor Treatment According to Sex

    doi: 10.3390/biomedicines12071424

    Figure Lengend Snippet: Univariate and multivariate Cox regression analysis for survival.

    Article Snippet: Sections were then incubated with goat anti-Ang2 primary antibody (AF623, R&D Systems, Inc., Minneapolis, MN, USA) at working dilution of 1:50 or mouse anti-podoplanin primary antibody (05463645001, Roche Diagnostics, Monza, MB, Italy), or rabbit anti-CLEC-2 primary antibody (LSB12627, LifeSpan BioSciences, Inc., Shirley, MA, USA) at working dilution of 1:50.

    Techniques: Biomarker Discovery